GoldBamboo.com - Knowledge is strong medicine
  

Aripiprazole in Adolescents with Schizophrenia - Article


  Not Signed In - Sign In / Register


Get Your Free Credit Report Right Now!

Zip Code:






Schizophrenia

Schizoid personality disorder; Schizotypal personality disorder 




Clinical Trial: Aripiprazole in Adolescents with Schizophrenia

This study is currently recruiting patients.

Sponsored by: Otsuka Maryland Research Institute
Information provided by: Otsuka Maryland Research Institute

Purpose

The purpose of this trial is to test the safety and efficacy of aripiprazole in adolescent patients with schizophrenia for a period of at least 6 weeks.

Condition Treatment or Intervention Phase
Schizophrenia
 Drug: Aripiprazole
Phase III

MedlinePlus related topics:  Schizophrenia

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study

Further Study Details: 

Expected Total Enrollment:  300

Study start: July 2004;  Expected completion: September 2006

Eligibility

Ages Eligible for Study:  13 Years   -   17 Years,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

Exclusion Criteria:

  • Patients diagnosed with schizoaffective disorder, major depressive disorder, delirium, or bipolar disorder

Location and Contact Information

Matthews Media Group      1-866-426-4480 

Alabama
      Local Institution, Birmingham,  Alabama,  United States; Not yet recruiting

Arkansas
      Local Institution, Little Rock,  Arkansas,  United States; Recruiting

      Local Institution, Little Rock,  Arkansas,  United States; Not yet recruiting

      Local Institution, Little Rock,  Arkansas,  United States; Not yet recruiting

California
      Local Institution, Rosemead,  California,  United States; Recruiting

      Local Institution, Sacramento,  California,  United States; Not yet recruiting

      Local Institution, Fresno,  California,  United States; Recruiting

      Local Institution, Temecula,  California,  United States; Recruiting

      Local Institution, Orange,  California,  United States; Not yet recruiting

      Local Institution, Riverside,  California,  United States; Recruiting

      Local Institution, Costa Mesa,  California,  United States; Recruiting

District of Columbia
      Local Institution, Washington,  District of Columbia,  United States; Recruiting

      Local Institution, Washington,  District of Columbia,  United States; Recruiting

Florida
      Local Institution, Miami,  Florida,  United States; Recruiting

      Local Institution, Miami,  Florida,  United States; Not yet recruiting

      Local Institution, Altamonte Springs,  Florida,  United States; Recruiting

      Local Institution, Hialeah,  Florida,  United States; Recruiting

      Local Institution, Jacksonville,  Florida,  United States; Recruiting

      Local Institution, Ft. Lauderdale,  Florida,  United States; Recruiting

      Local Institution, Tampa,  Florida,  United States; Recruiting

      Local Institution, Orange City,  Florida,  United States; Recruiting

Georgia
      Local Institution, Atlanta,  Georgia,  United States; Not yet recruiting

Hawaii
      Local Institution, Honolulu,  Hawaii,  United States; Recruiting

Illinois
      Local Institution, Chicago,  Illinois,  United States; Not yet recruiting

Kansas
      Local Institution, Kansas City,  Kansas,  United States; Not yet recruiting

Kentucky
      Local Institution, Louisville,  Kentucky,  United States; Not yet recruiting

      Local Institution, Lexington,  Kentucky,  United States; Recruiting

Louisiana
      Local Institution, Metairie,  Louisiana,  United States; Recruiting

      Local Institution, New Orleans,  Louisiana,  United States; Recruiting

      Local Institution, Lake Charles,  Louisiana,  United States; Recruiting

Massachusetts
      Local Institution, Somerville,  Massachusetts,  United States; Not yet recruiting

Michigan
      Local Institution, Clinton,  Michigan,  United States; Recruiting

Missouri
      Local Institution, Kansas City,  Missouri,  United States; Not yet recruiting

      Local Institution, St. Charles,  Missouri,  United States; Not yet recruiting

New York
      Local Institution, Rochester,  New York,  United States; Recruiting

      Local Institution, Olean,  New York,  United States; Recruiting

      Local Institution, Elmsford,  New York,  United States; Not yet recruiting

      Local Institution, New York,  New York,  United States; Not yet recruiting

North Carolina
      Local Institution, Chapel Hill,  North Carolina,  United States; Not yet recruiting

Ohio
      Local Institution, Cleveland,  Ohio,  United States; Not yet recruiting

      Local Institution, Lyndhurst,  Ohio,  United States; Recruiting

Oklahoma
      Local Institution, Oklahoma City,  Oklahoma,  United States; Recruiting

      Local Institution, Oklahoma City,  Oklahoma,  United States; Recruiting

Pennsylvania
      Local Institution, Philadelphia,  Pennsylvania,  United States; Recruiting

      Local Institution, Bala Cynwyd,  Pennsylvania,  United States; Recruiting

Tennessee
      Local Institution, Memphis,  Tennessee,  United States; Recruiting

Texas
      Local Institution, Houston,  Texas,  United States; Recruiting

      Local Institution, San Antonio,  Texas,  United States; Recruiting

      Local Institution, Bellaire,  Texas,  United States; Recruiting

      Local Institution, Desoto,  Texas,  United States; Recruiting

      Local Institution, Houston,  Texas,  United States; Not yet recruiting

Utah
      Local Institution, Salt Lake City,  Utah,  United States; Not yet recruiting

Washington
      Local Institution, Seattle,  Washington,  United States; Not yet recruiting

      Local Institution, Kirkland,  Washington,  United States; Recruiting

      Local Institution, Kirkland,  Washington,  United States; Recruiting

      Local Institution, Spokane,  Washington,  United States; Not yet recruiting

Wisconsin
      Local Institution, Wauwatosa,  Wisconsin,  United States; Recruiting

More Information

Study ID Numbers:  31-03-239
Record last reviewed:  January 2005
Last Updated:  January 26, 2005
Record first received:  January 19, 2005
ClinicalTrials.gov Identifier:  NCT00102063
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 8, 2005

Resources



[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $30 a year, a savings of 70% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Schizophrenia.

December 3, 2009



Page Updated: October 15, 2009
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.